The ergot derivative, bromocriptine mesylate (Cycloset) is approved by the Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 ...

Bromocriptine quick release (BCQR) improves blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in adolescents with type 1 diabetes (T1D), a placebo-controlled ...

New University of Pittsburgh research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications. The study, including experiments in ...

Please provide your email address to receive an email when new articles are posted on . “We know that abnormalities in the large vessels around the heart, the aorta and its primary branches begin to ...